Activity of Carbetimer in a human tumor cloning system
- PMID: 6469499
- DOI: 10.1007/BF00173787
Activity of Carbetimer in a human tumor cloning system
Abstract
The antitumor activity of Carbetimer was tested against 171 patient's tumors in a human tumor cloning system. Sixty-seven tumor specimens had adequate growth to be considered evaluable. In 21 specimens survival of tumor colony forming units was less than or equal to 50% that in control plates. Antitumor effect was most impressive in carcinomas of the breast, ovary, and lung. This information will be useful in planning disease oriented Phase II trials.